Why a Big Insurer Is Dropping OxyContin

Cigna’s move to stop covering the controversial drug is a reaction to the opioid crisis—but experts say it’s also a business decision.


Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.